BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab
This article is protected by copyright. All rights reserved.
Source: American Journal of Hematology - Category: Hematology Authors: Sarah Huet, Edith Szafer ‐Glusman, Bruno Tesson, Luc Xerri, Wayne J. Fairbrother, Kiran Mukhyala, Chris Bolen, Elizabeth Punnoose, Laurie Tonon, Catherine Chassagne‐Clément, Pierre Feugier, Alain Viari, Fabrice Jardin, Gilles Salles, Pierre Sujobert Tags: Research Article Source Type: research